{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"description":"Disease free survival refers to patients with no evidence of disease after transplant, at the 12 month time point.","groups":[{"description":"Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant","id":"OG000","title":"Haploidentical Transplant"}],"paramType":"NUMBER","populationDescription":"14 patients were alive at one year and therefore were eligible to be evaluated for disease free survival at 1 year","reportingStatus":"POSTED","timeFrame":"12 months","title":"Disease Free Survival at 12 Months","type":"SECONDARY","unitOfMeasure":"participants"}